Childhood cancers trials in Singapore

In Singapore 19 Also abroad 2459

19 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Where
Singapore
Age
12 years and over
People
355 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT04924075 · EU 2023-504853-11-00
Phase 2Taking people
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Where
Singapore
Age
1 year to 18 years
People
50 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07354074
Phase 4Taking people
Asciminib Roll-over Study
Where
Singapore
Age
7 years to 100 years
People
347 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00
Phase 1/2Taking people
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Where
Singapore
Age
12 years and over
People
840 worldwide
Run by
Nuvalent Inc.
See details and how to joinNCT05384626 · EU 2024-514266-39-00
Phase 3Taking people
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Where
Singapore
Age
12 years and over
People
468 worldwide
Run by
Syndax Pharmaceuticals
See details and how to joinNCT07211958 · EU 2025-522279-27-00
Phase 1/2Taking people
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Where
Kent Ridge, Singapore
Age
12 years and over
People
300 worldwide
Run by
PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750
Phase 1/2Taking people
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Where
Singapore
Age
Up to 25 years
People
75 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT04094610 · EU 2023-506464-14-00
Phase 1/2Taking people
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Where
Singapore
Age
12 years and over
People
359 worldwide
Run by
Nuvalent Inc.
See details and how to joinNCT05118789 · EU 2024-511793-71-00
No phaseTaking people
Developing and Testing the Effectiveness of a Skin Cancer Self-Detection Educational Program
Where
Singapore
Age
16 years and over
People
280
Run by
National University Hospital, Singapore
See details and how to joinNCT07247123
Phase 1/2Taking people
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Where
Singapore
Age
12 years and over
People
500 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00
No phaseTaking people
Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project
Where
Singapore
Age
12 years and over
People
5,500
Run by
National Cancer Centre, Singapore
See details and how to joinNCT02806388
Phase 3Taking people
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
Where
Singapore
People
510 worldwide
Run by
Jazz Pharmaceuticals
See details and how to joinNCT05580562 · EU 2022-502051-56-00
Phase 1/2Taking people
Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas
Where
Singapore
Age
10 years to 80 years
People
30
Run by
National University Hospital, Singapore
See details and how to joinNCT07319676
Phase 1/2Taking people
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Where
Singapore
Age
12 years and over
People
606 worldwide
Run by
Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555
Phase 2Taking people
Randomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin, Pembrolizumab and Bevacizumab (GPPB) in Nasopharyngeal Cancer
Where
Singapore
Age
21 months to 99 years
People
50
Run by
National University Hospital, Singapore
See details and how to joinNCT05305131
Phase 2Taking people
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
Where
Singapore
Age
6 months to 25 years
People
141 worldwide
Run by
Day One Biopharmaceuticals, Inc.
See details and how to joinNCT04775485 · EU 2024-510691-20-00
No phaseTaking people
Outcomes of a Novel Technique Minimal Scar Mastectomy
Where
Singapore
People
100
Run by
KK Women's and Children's Hospital
See details and how to joinNCT06676761
Phase 2Taking people
Ma-Spore ALL 2020 Study
Where
Singapore
Age
Up to 40 years
People
500 worldwide
Run by
National University Hospital, Singapore
See details and how to joinNCT06336395
Phase 2Taking people
CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol
Where
Singapore
Age
0 years to 70 years
People
40
Run by
KK Women's and Children's Hospital
See details and how to joinNCT05648019